Omega Healthcare Investors Inc (OHI)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $14.97B
Last updated: Nov 17, 2026 at 11:06 AM ET
Omega Healthcare Investors Inc (OHI) P/E Ratio & Valuation History
Omega Healthcare Investors (OHI) trades at 14.1x its 2026 FFO estimate. Its forward P/E is 10.1x. It trades at 10.9x sales and 2.6x book value. Its P/S is above its 5-year median of 10.0x.
Current Multiples
Its P/FFO of 14.1x uses the 2026 FFO estimate of $3.34 per share. Its enterprise value is 15.1x its EBITDA. PEG is left out because the growth rate behind it, P/E divided by PEG, is under 2% a year.
| Multiple | Value |
|---|---|
| P/FFO (2026 estimate) | 14.1x |
| P/E (trailing) | 17.7x |
| Forward P/E | 10.1x |
| Price to sales | 10.9x |
| Price to book | 2.6x |
| EV/EBITDA | 15.1x |
| Price to FCF | 17.5x |
| EV/FCF | 22.4x |
| PEG | N/A |
| FCF yield | 5.7% |
Historical Medians
Against its 10-year medians, its P/E is 16.5% below 21.2x, its P/S is 12.4% above 9.7x and its P/B is 23.8% above 2.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 17.7x | 21.4x | 21.2x |
| P/S | 10.9x | 10.0x | 9.7x |
| P/B | 2.6x | 2.2x | 2.1x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 13.4x in 2022 to 35.3x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $44.34 | 21.8x | 13.2x | 2.7x |
| 2024 | $37.85 | 23.1x | 11.9x | 2.4x |
| 2023 | $30.66 | 22.7x | 9.5x | 2.2x |
| 2022 | $27.95 | 13.4x | 6.6x | 1.9x |
| 2021 | $29.59 | 18.4x | 8.5x | 1.9x |
| 2020 | $36.32 | 35.3x | 12.0x | 2.2x |
| 2019 | $42.35 | 23.7x | 11.8x | 2.3x |
| 2018 | $35.15 | 24.1x | 11.8x | 2.2x |
| 2017 | $27.54 | 14.6x | 5.7x | 1.6x |
| 2016 | $31.26 | 14.6x | 3.6x | 1.7x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OHI
What is OHI's forward P/E ratio?
Omega Healthcare Investors has a forward P/E ratio of 10.1x. It trades at 14.1x its 2026 FFO estimate.
Is OHI stock overvalued?
Omega Healthcare Investors trades at 14.1x its 2026 FFO estimate. GNG's valuation label for OHI is Fairly valued.
What is OHI's price to sales ratio?
Omega Healthcare Investors has a price to sales ratio of 10.9x.
What is Omega Healthcare Investors's average P/E ratio over 5 years?
Omega Healthcare Investors's median P/E over the last 5 years is 21.4x, from 60 month-end values through Oct 2026. It trades at 14.1x its 2026 FFO estimate.
OHI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors